TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.

Selly Ba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.